915213-24-0

Basic information

• Product Name: METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE
• Synonyms: METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE;5,5,5-TRIFLUORO-3-OXO-PENTANOIC ACID METHYL ESTER;Pentanoic acid, 5,5,5-trifluoro-3-oxo-, methyl ester
• CAS NO: 915213-24-0
• Molecular Formula: C6H7F3O3
• Molecular Weight: 184.112
• Mol File: 915213-24-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE(915213-24-0)
• EPA Substance Registry System: METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE(915213-24-0)

Safety Data

• Hazardous Substances Data: 915213-24-0(Hazardous Substances Data)

Usage

General Description

Methyl 5,5,5-trifluoro-3-oxopentanoate is a chemical compound with the molecular formula C6H7F3O3. It is a colorless liquid with a fruity odor and is often used in the production of pharmaceuticals, agrochemicals, and other specialty chemicals. METHYL 5,5,5-TRIFLUORO-3-OXOPENTANOATE is known for its high reactivity and is commonly used as a reagent in organic synthesis. It is also used in the flavor and fragrance industry due to its fruity aroma. Additionally, methyl 5,5,5-trifluoro-3-oxopentanoate has applications in the development of new materials and technologies, making it a versatile and important chemical in various industries.

Upstream product

• 67-56-1 methanol 
• 2033-24-1 cycl-isopropylidene malonate 
• 41463-83-6 3,3,3-trifluoropropanoyl chloride 

Downstream Products

• 1433903-12-8 6-chloro-4-phenyl-2-(2,2,2-trifluoro-ethyl)-quinoline-3-carboxylic acid methyl ester 
• 86944-08-3 (2-amino-6-oxo-1,6-dihydro-pyrimidin-4-yl)-acetic acid methyl ester 

Relevant articles and documents

P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS

The present application provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R4 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient.

ARYL-QUINOLINE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.

Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia

A compound having the general structure of Formula (I): or a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, wherein: Q is selected from the group consisting of: and L is selected from the group consisting of: or a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome and dyslipidemia.